Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-175
Closed -$4.17K – 714
2024
Q4
$4.17K Hold
175
– – ﹤0.01% 783
2024
Q3
$4.9K Buy
+175
New +$4.94K ﹤0.01% 786
2023
Q1
– Sell
-12,662
Closed -$218K – 183
2022
Q4
$218K Buy
+12,662
New +$225K 0.11% 148

Other funds holding RXO

Oarsman Capital's RXO Position: Q1 2025 in Review

Oarsman Capital sold out of RXO (RXO) in Q1 2025, closing a stake of 175 shares — an estimated $4.17K sold.

Oarsman Capital first reported a position in RXO in Q4 2022 and held it in 3 quarters. The position peaked at $218K in Q4 2022. 258 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • Oarsman Capital reported no remaining RXO position as of Q1 2025 after selling out during the quarter.
  • Oarsman Capital sold 175 RXO shares in Q1 2025, an estimated $4.17K.
  • Oarsman Capital first reported a position in RXO in Q4 2022 and held it in 3 quarters.
  • Oarsman Capital's RXO position peaked at $218K in Q4 2022.
  • 258 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.